# Kamlesh Khunti

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/kamlesh-khunti/

## Facts

| Field | Value |
| --- | --- |
| Citations | 121,053 |
| Field | Diabetes Treatment and Management |
| h-index | 166 |
| i10-index | 1,091 |
| Last Known Institution | University of Leicester |
| OpenAlex ID | https://openalex.org/A5083222970 |
| ORCID iD | 0000-0003-2343-7099 |
| Works | 2,083 |

## Researcher papers

Showing 12 of 25.

- [2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD](https://scholariq.org/papers/2019-esc-guidelines-on-diabetes-pre-diabetes-and-cardiovascular-diseases/)
- [Type 2 diabetes](https://scholariq.org/papers/type-2-diabetes/)
- [2. Classification and Diagnosis of Diabetes:<i>Standards of Care in Diabetes—2023</i>](https://scholariq.org/papers/2-classification-and-diagnosis-of-diabetes-i-standards-of-care-in-diabetes-2023/)
- [2. Diagnosis and Classification of Diabetes:<i>Standards of Care in Diabetes—2024</i>](https://scholariq.org/papers/2-diagnosis-and-classification-of-diabetes-i-standards-of-care-in-diabetes-2024/)
- [Sedentary time in adults and the association with diabetes, cardiovascular disease and death: systematic review and meta-analysis](https://scholariq.org/papers/sedentary-time-in-adults-and-the-association-with-diabetes-cardiovascular/)
- [2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes](https://scholariq.org/papers/2023-esc-guidelines-for-the-management-of-cardiovascular-disease-in-patients/)
- [The prevalence of co‐morbid depression in adults with Type 2 diabetes: a systematic review and meta‐analysis](https://scholariq.org/papers/the-prevalence-of-co-morbid-depression-in-adults-with-type-2-diabetes-a/)
- [KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease](https://scholariq.org/papers/kdigo-2022-clinical-practice-guideline-for-diabetes-management-in-chronic-kidney/)
- [Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis](https://scholariq.org/papers/pharmacological-and-lifestyle-interventions-to-prevent-or-delay-type-2-diabetes/)
- [2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2025](https://scholariq.org/papers/2-diagnosis-and-classification-of-diabetes-standards-of-care-in-diabetes-2025/)
- [Practical recommendations for the management of diabetes in patients with COVID-19](https://scholariq.org/papers/practical-recommendations-for-the-management-of-diabetes-in-patients-with-covid/)
- [Diabetes Management in Chronic Kidney Disease: A Consensus Report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO)](https://scholariq.org/papers/diabetes-management-in-chronic-kidney-disease-a-consensus-report-by-the-american-2/)

## Researcher topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Diabetes, Cardiovascular Risks, and Lipoproteins](https://scholariq.org/topics/diabetes-cardiovascular-risks-and-lipoproteins/)
- [Diabetes Management and Research](https://scholariq.org/topics/diabetes-management-and-research/)
- [Diabetes Management and Education](https://scholariq.org/topics/diabetes-management-and-education/)
- [Chronic Disease Management Strategies](https://scholariq.org/topics/chronic-disease-management-strategies/)

## Researcher university

- [University of Leicester](https://scholariq.org/institutions/university-of-leicester/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.